Overview
- Authors:
-
-
Zhiguo Wang
-
Department of Pharmacology, Harbin Medical University, Harbin, China
-
Baofeng Yang
-
Department of Pharmacology, Harbin Medical University, Harbin, China
- Provides comprehensive, in-depth mechanisms behind the knowledge and methodology of Polypharmacology
- Emphasis on rationally designed Polypharmacology or “multi-target, single-drug (MTSD)” pharmacology
- Contains a wide collection of the state-of-the-art Polypharmacology technologies
Access this book
Other ways to access
About this book
There is a growing interest in unmet needs for the development of a new discipline in drug discovery and in university education on polypharmacology. However, there has not been a book with the comprehensive compilation of basic knowledge and advanced methodology that is needed. This book aims to meet the needs making Polypharmacology a new sub-discipline of Pharmacology, not only being a hot area of pharmacological research and education but also a new paradigm for drug discovery. It contains the contents covering the entire scope of Polypharmacology including systemic in-depth exposition of basic knowledge, novel concepts, innovative technologies, and translational and clinical applications by showcasing state-of-the-art strategies and step-by-step instructions of cutting-edge methods. The contents of this book targets broad readerships including scientists in pharmacology research and drug development, and university teachers and graduates in medical school or school of pharmacy.
Similar content being viewed by others
Article
Open access
16 February 2024
Table of contents (21 chapters)
-
-
- Zhiguo Wang, Baofeng Yang
Pages 1-41
-
- Zhiguo Wang, Baofeng Yang
Pages 43-72
-
- Zhiguo Wang, Baofeng Yang
Pages 73-132
-
- Zhiguo Wang, Baofeng Yang
Pages 133-198
-
- Zhiguo Wang, Baofeng Yang
Pages 199-229
-
- Zhiguo Wang, Baofeng Yang
Pages 231-269
-
- Zhiguo Wang, Baofeng Yang
Pages 271-299
-
- Zhiguo Wang, Baofeng Yang
Pages 301-321
-
- Zhiguo Wang, Baofeng Yang
Pages 323-342
-
- Zhiguo Wang, Baofeng Yang
Pages 343-374
-
- Zhiguo Wang, Baofeng Yang
Pages 375-396
-
- Zhiguo Wang, Baofeng Yang
Pages 397-533
-
- Zhiguo Wang, Baofeng Yang
Pages 535-592
-
- Zhiguo Wang, Baofeng Yang
Pages 593-623
-
- Zhiguo Wang, Baofeng Yang
Pages 625-646
-
- Zhiguo Wang, Baofeng Yang
Pages 647-659
-
- Zhiguo Wang, Baofeng Yang
Pages 661-676
-
- Zhiguo Wang, Baofeng Yang
Pages 677-736
-
- Zhiguo Wang, Baofeng Yang
Pages 737-780
About the authors
Zhiguo Wang PhD received his PhD in cardiovascular pharmacology from McGill University, Canada. He is presently the Director of the Division of Drug Discovery, Meditech Institute of Research and Advance (USA) and a Distinguished Professor in the Department of Pharmacology, Harbin Medical University. He is an author of over 150 research articles in prestigious scientific journals and of 6 monographs and 15 book chapters with renowned scientific publishers. His research interests cover cardiovascular disease and pharmacology, molecular pharmacology, epigenetic polypharmacology. His research group is one of the earliest investigators who proposed “one drug, multiple targets” polypharmacology concept and provided the experimental evidence in support of the epigenetic polypharmacology.